From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity
Sequence analyses highlight a massive peptide sharing between immunoreactive Epstein-Barr virus (EBV) epitopes and human proteins that—when mutated, deficient or improperly functioning—associate with tumorigenesis, diabetes, lupus, multiple sclerosis, rheumatoid arthritis, and immunodeficiencies, am...
Main Authors: | Darja Kanduc, Yehuda Shoenfeld |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2020-08-01
|
Series: | Global Medical Genetics |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1715641 |
Similar Items
-
Antibody Cross-Reactivity in Auto-Immune Diseases
by: Nicole Hartwig Trier, et al.
Published: (2023-09-01) -
EBV-Associated Cancer and Autoimmunity: Searching for Therapies
by: Giovanni Capone, et al.
Published: (2015-02-01) -
From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry
by: Darja Kanduc
Published: (2020-07-01) -
Anti-Cytokine Autoantibodies in Systemic Lupus Erythematosus
by: Hwee Siew Howe, et al.
Published: (2019-12-01) -
Frequency of EBV Infection in HIV Positives Patients
by: alireza Abdollahi, et al.
Published: (2014-12-01)